Want to see LCTC full AI Analyst Report?
Top Page
Lifeloc Technologies
(OTC:LCTC)
Select Model
Select Model
Rating:59Neutral
Price Target:
$4.50
▲(16.28% Upside)
Action:Reiterated
Date:09/30/26
The score is driven mainly by mixed fundamentals: strong TTM revenue rebound and a meaningfully de-risked balance sheet are positives, but ongoing losses keep financial quality moderate. Technicals add support with an established uptrend and constructive momentum, while valuation is constrained by the negative P/E. A modest positive corporate event improves visibility but is not sufficient to outweigh profitability risk.
Positive Factors
Revenue rebound and gross margin
The sharp TTM revenue rebound indicates renewed demand for Lifeloc’s breath alcohol testing products, while improved gross margin shows better economics on sales. If maintained, this combination can provide a stronger base for scaling the business and funding future product development.
Negative Factors
Persistent unprofitability
Ongoing losses show that the recent revenue recovery has not yet translated into durable operating profitability. Negative EBIT and EBITDA limit internally generated resources, weaken resilience if demand softens, and make execution on growth initiatives more dependent on achieving further margin improvement.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue rebound and gross margin
The sharp TTM revenue rebound indicates renewed demand for Lifeloc’s breath alcohol testing products, while improved gross margin shows better economics on sales. If maintained, this combination can provide a stronger base for scaling the business and funding future product development.
Read all positive factors
Lifeloc Technologies (LCTC) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$11.29M
Dividend YieldN/A
Average Volume (3M)1.41K
Price to Earnings (P/E)―
Beta (1Y)0.23
Revenue Growth9.13%
EPS Growth-75.10%
CountryUS
Employees37
SectorTechnology
Sector Strength88
IndustryHardware, Equipment & Parts
Share Statistics
EPS (TTM)-0.75
Shares Outstanding2,752,616
10 Day Avg. Volume305
30 Day Avg. Volume1,411
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)1.60
Price to Sales (P/S)0.73
P/FCF Ratio-14.26
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Lifeloc Technologies Business Overview & Revenue Model
Company Description
Lifeloc Technologies, Inc. develops, manufactures, and markets portable hand-held and fixed station breathalyzers and related accessories for law enforcement, workplace, corrections, original equipment manufacturing, and consumer markets worldwide...
How the Company Makes Money
Lifeloc primarily makes money by selling breath alcohol testing devices (breathalyzers) to institutional and individual customers. Revenue is also generated from recurring and ancillary sales tied to the installed base of devices, including replac...
Lifeloc Technologies Financial Statement Overview
Summary
Income Statement
38
Negative
Balance Sheet
66
Positive
Cash Flow
55
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Mar 2024 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.27M | 9.03M | 8.54M | 9.33M | 8.48M | 7.05M |
| Gross Profit | 3.89M | 3.64M | 3.45M | 4.04M | 3.07M | 3.06M |
| EBITDA | -463.08K | -786.57K | -1.07M | 139.45K | 98.46K | 937.83K |
| Net Income | -2.07M | -2.47M | -1.05M | 205.61K | -455.76K | 675.97K |
Balance Sheet | ||||||
| Total Assets | 7.08M | 6.69M | 8.72M | 8.69M | 8.52M | 8.95M |
| Cash, Cash Equivalents and Short-Term Investments | 908.21K | 746.00K | 1.24M | 1.77M | 2.35M | 2.57M |
| Total Debt | 2.28M | 1.83M | 1.80M | 1.22M | 1.27M | 1.32M |
| Total Liabilities | 3.26M | 2.58M | 2.50M | 2.33M | 2.36M | 2.36M |
| Stockholders Equity | 3.82M | 4.10M | 6.23M | 6.36M | 6.16M | 6.59M |
Cash Flow | ||||||
| Free Cash Flow | 562.84K | -460.77K | -2.02M | -533.96K | -168.25K | -85.53K |
| Operating Cash Flow | 472.75K | 2.02K | -1.33M | -525.74K | 54.33K | 182.94K |
| Investing Cash Flow | -112.13K | -354.38K | -689.45K | -8.21K | -222.58K | -268.48K |
| Financing Cash Flow | 416.69K | 355.95K | 1.49M | -52.18K | -50.66K | 462.13K |
Lifeloc Technologies Technical Analysis
Positive
3.87
Price Trends
3.98
Positive
3.32
Positive
2.76
Positive
Market Momentum
0.04
Positive
52.01
Neutral
33.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For LCTC, the sentiment is Positive. The current price of 3.87 is below the 20-day moving average (MA) of 4.12, below the 50-day MA of 3.98, and above the 200-day MA of 2.76, indicating a neutral trend. The MACD of 0.04 indicates Positive momentum. The RSI at 52.01 is Neutral, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for LCTC.
Lifeloc Technologies Risk Analysis
Lifeloc Technologies disclosed 36 risk factors in its most recent earnings report. Lifeloc Technologies reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Lifeloc Technologies Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | $11.29M | -5.24 | -47.35% | ― | 9.13% | -75.10% | |
53 Neutral | $93.58M | -76.67 | -10.92% | ― | 7.85% | 45.80% | |
48 Neutral | $24.36M | -11.13 | -168.53% | ― | -46.47% | -26.00% | |
47 Neutral | $71.74M | 813.04 | 0.15% | ― | 25.56% | ― | |
45 Neutral | $115.70M | -1.14 | -92.81% | ― | 28.49% | -296.38% | |
38 Underperform | $377.10K | -0.04 | -310.87% | ― | 17.67% | 92.17% |
* Technology Sector Average
LCTC
Lifeloc Technologies
4.10
1.05
34.43%
REFR
Research Frontiers
0.69
-0.76
-52.14%
CPSH
CPS Technologies
3.79
0.15
4.12%
LINK
Interlink Electronics
5.96
-2.95
-33.11%
SOBR
SOBR Safe
0.05
-3.40
-98.43%
KULR
KULR Technology Group
2.58
-2.18
-45.80%
Lifeloc Technologies Corporate Events
Business Operations and StrategyProduct-Related Announcements
Lifeloc Technologies Highlights Growth at Lytham Investor Conference
Positive
Sep 29, 2026
On September 28, 2026, Lifeloc Technologies announced it will participate in the virtual Lytham Partners Fall 2026 Investor Conference, scheduled for September 29-30, 2026. The company will deliver a webcast presentation on September 29 at 2:45 p....
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.